STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed
China has tightened regulations on investigator-initiated trials, with consequences not just for Chinese researchers but some Americans, too.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.